Sanofi to Buy U.S. Autoimmune Drugmaker in $3.4 Billion Deal

(Bloomberg) -- Sanofi plans to acquire San Francisco, California-based Principia Biopharma Inc in a deal with an enterprise value of $3.4 billion as the French drugmaker pivots toward innovative th...